GERON CORP Defined Contribution Plan, Cost
GERON CORP (GERN) reported Defined Contribution Plan, Cost of $9.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2022-03-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2022-03-10
- GERON CORP defined contribution plan, cost for the quarter ending 2019-12-31 was $0.00.
- GERON CORP defined contribution plan, cost for the quarter ending 2019-09-30 was $0.00.
- GERON CORP defined contribution plan, cost for the quarter ending 2019-06-30 was $0.00.
- GERON CORP defined contribution plan, cost for the quarter ending 2019-03-31 was $9.00K, a 10.00% decline year-over-year.
- GERON CORP defined contribution plan, cost for fiscal 2019 was $9.00K, a 0.00% change from fiscal 2018.
- GERON CORP defined contribution plan, cost for fiscal 2018 was $9.00K, a 71.88% decline from fiscal 2017.
- GERON CORP defined contribution plan, cost for fiscal 2017 was $32.00K, a 47.54% decline from fiscal 2016.
- GERON CORP defined contribution plan, cost for fiscal 2016 was $61.00K, a 62.11% decline from fiscal 2015.
| Period end | Defined Contribution Plan, Cost 3 month | Defined Contribution Plan, Cost 6 month | Defined Contribution Plan, Cost 9 month | Defined Contribution Plan, Cost 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $0.00 derived: sum of 2 quarters · filed 2022-03-10 | $0.00 derived: sum of 3 quarters · filed 2022-03-10 | $9.00K 10-K · filed 2022-03-10 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $0.00 derived: sum of 2 quarters · filed 2020-11-05 | $9.00K 10-Q · filed 2020-11-05 | $8.00K derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $9.00K 10-Q · filed 2020-08-06 | $8.00K derived: sum of 3 quarters · filed 2021-03-11 | $8.00K derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-03-31 | $9.00K 10-Q · filed 2020-05-28 | $8.00K derived: sum of 2 quarters · filed 2021-03-11 | $8.00K derived: sum of 3 quarters · filed 2021-03-11 | $8.00K derived: sum of 4 quarters · filed 2021-03-11 |
| 2018-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$1.00K derived: sum of 2 quarters · filed 2021-03-11 | -$1.00K derived: sum of 3 quarters · filed 2021-03-11 | $9.00K 10-K · filed 2021-03-11 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $0.00 derived: sum of 2 quarters · filed 2019-11-06 | $10.00K 10-Q · filed 2019-11-06 | $10.00K derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $10.00K 10-Q · filed 2019-08-01 | $10.00K derived: sum of 3 quarters · filed 2020-03-12 | $10.00K derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | $10.00K 10-Q · filed 2019-05-02 | $10.00K derived: sum of 2 quarters · filed 2020-03-12 | $10.00K derived: sum of 3 quarters · filed 2020-03-12 | $10.00K derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $0.00 derived: sum of 2 quarters · filed 2020-03-12 | $0.00 derived: sum of 3 quarters · filed 2020-03-12 | $32.00K 10-K · filed 2020-03-12 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $0.00 derived: sum of 2 quarters · filed 2018-11-01 | $32.00K 10-Q · filed 2018-11-01 | $33.00K derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | $32.00K 10-Q · filed 2018-07-31 | $33.00K derived: sum of 3 quarters · filed 2019-03-07 | $36.00K derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-03-31 | $32.00K 10-Q · filed 2018-05-10 | $33.00K derived: sum of 2 quarters · filed 2019-03-07 | $36.00K derived: sum of 3 quarters · filed 2019-03-07 | $40.00K derived: sum of 4 quarters · filed 2019-03-07 |
| 2016-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $4.00K derived: sum of 2 quarters · filed 2019-03-07 | $8.00K derived: sum of 3 quarters · filed 2019-03-07 | $61.00K 10-K · filed 2019-03-07 |
| 2016-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $7.00K derived: sum of 2 quarters · filed 2017-11-01 | $60.00K 10-Q · filed 2017-11-01 | $60.00K derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $57.00K 10-Q · filed 2017-08-09 | $57.00K derived: sum of 3 quarters · filed 2018-03-16 | $60.00K derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-03-31 | $53.00K 10-Q · filed 2017-05-09 | $53.00K derived: sum of 2 quarters · filed 2018-03-16 | $56.00K derived: sum of 3 quarters · filed 2018-03-16 | $60.00K derived: sum of 4 quarters · filed 2018-03-16 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $3.00K derived: sum of 2 quarters · filed 2018-03-16 | $7.00K derived: sum of 3 quarters · filed 2018-03-16 | $161.00K 10-K · filed 2018-03-16 |
| 2015-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $7.00K derived: sum of 2 quarters · filed 2016-11-03 | $161.00K 10-Q · filed 2016-11-03 | |
| 2015-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $158.00K 10-Q · filed 2016-08-03 | ||
| 2015-03-31 | $154.00K 10-Q · filed 2016-05-05 | |||
| 2014-12-31 | $111.00K 10-K · filed 2017-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |